Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Beigene, Biontech, Celltrion, Cocrystal, Daiichi Sankyo, Himalaya, Intellia, Janssen-Cilag, Johnson & Johnson, Moderna, Pfizer, RDIF, Takeda.